Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis
- PMID: 24445837
- DOI: 10.1097/INF.0000000000000260
Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis
Abstract
After exposure to a teacher with multidrug-resistant pulmonary tuberculosis, 31 children developed latent infection. Twenty-six were treated with levofloxacin and pyrazinamide. Twelve required a change in therapy secondary to adverse effects. The most common adverse effects included abdominal pain, arthralgias/myalgias and elevated transaminases. All children reported at least 1 adverse effect. Fifteen children completed treatment. All adverse effects were transient.
Comment in
-
Toxicity and tolerability of fluoroquinolone-based preventive therapy for childhood contacts of multidrug-resistant tuberculosis.Pediatr Infect Dis J. 2014 Oct;33(10):1098-9. doi: 10.1097/INF.0000000000000369. Pediatr Infect Dis J. 2014. PMID: 25361192 No abstract available.
-
Reply: To PMID 24445837.Pediatr Infect Dis J. 2014 Oct;33(10):1099-100. doi: 10.1097/INF.0000000000000437. Pediatr Infect Dis J. 2014. PMID: 25361193 No abstract available.
Similar articles
-
Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and Levofloxacin.Pediatr Infect Dis J. 2019 Oct;38(10):1025-1026. doi: 10.1097/INF.0000000000002413. Pediatr Infect Dis J. 2019. PMID: 31335574
-
Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis.CMAJ. 2002 Jul 23;167(2):131-6. CMAJ. 2002. PMID: 12160118 Free PMC article.
-
Toxicity and tolerability of fluoroquinolone-based preventive therapy for childhood contacts of multidrug-resistant tuberculosis.Pediatr Infect Dis J. 2014 Oct;33(10):1098-9. doi: 10.1097/INF.0000000000000369. Pediatr Infect Dis J. 2014. PMID: 25361192 No abstract available.
-
[Children exposed to multidrug-resistant tuberculosis: How should we manage? Analysis of 46 child contacts and review of the literature].Rev Pneumol Clin. 2015 Dec;71(6):335-41. doi: 10.1016/j.pneumo.2015.05.003. Epub 2015 Jul 17. Rev Pneumol Clin. 2015. PMID: 26195117 Review. French.
-
Present-day treatment of tuberculosis and latent tuberculosis infection.Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 1:41-6. doi: 10.1016/S0213-005X(11)70017-9. Enferm Infecc Microbiol Clin. 2011. PMID: 21420566 Review.
Cited by
-
Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA.Emerg Infect Dis. 2015 Mar;21(3):500-3. doi: 10.3201/eid2103.141313. Emerg Infect Dis. 2015. PMID: 25695482 Free PMC article.
-
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.Am J Respir Crit Care Med. 2019 Nov 15;200(10):e93-e142. doi: 10.1164/rccm.201909-1874ST. Am J Respir Crit Care Med. 2019. PMID: 31729908 Free PMC article.
-
An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP+.BMC Infect Dis. 2018 Oct 5;18(1):506. doi: 10.1186/s12879-018-3402-4. BMC Infect Dis. 2018. PMID: 30290790 Free PMC article.
-
Risk Factors for Adverse Events in Household Contacts Prescribed Preventive Treatment for Drug-resistant Tuberculosis Exposure.Clin Infect Dis. 2021 May 18;72(10):1709-1715. doi: 10.1093/cid/ciaa327. Clin Infect Dis. 2021. PMID: 32266942 Free PMC article.
-
Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study.Clin Infect Dis. 2020 Jan 16;70(3):436-445. doi: 10.1093/cid/ciz254. Clin Infect Dis. 2020. PMID: 30919881 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources